Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD69 | Q07108 | 2/20 | 0.56 |
| ▸ | ELANE | P08246 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.43 |
| ▸ | RXRA | P19793 | 9/20 | 0.40 |
| ▸ | PPARG | P37231 | 9/20 | 0.40 |
| ▸ | RARG | P13631 | 3/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | RARA | P10276 | 3/20 | 0.38 |
| ▸ | RARB | P10826 | 3/20 | 0.38 |
| ▸ | RXRB | P28702 | 3/20 | 0.38 |
| ▸ | RXRG | P48443 | 3/20 | 0.38 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL817661 | 0.84 | CD69 (0.40) | CD69ELANESMN1; SMN2CYP2C19PTGDR2 | |
| SCHEMBL818354 | 0.80 | KMT2A (0.52) | SMN1; SMN2TSHRKMT2A | |
| SCHEMBL15235861 | 0.79 | CYP3A4 (0.38) | SMN1; SMN2CYP2C19RXRAPPARGRARG | |
| SCHEMBL15235863 | 0.73 | CYP3A4 (0.35) | SMN1; SMN2CYP2C19RXRAPPARGRARG | |
| SCHEMBL5325453 | 0.73 | CD69 (0.64) | CD69ELANESMN1; SMN2CYP2C19PTGDR2 | |
| SCHEMBL15241281 | 0.72 | MEN1 (0.34) | CYP2C19RXRAPPARGRARGCYP1A2 | |
| SCHEMBL2184946 | 0.72 | CD69 (1.00) | CD69ELANESMN1; SMN2CYP2C19PTGDR2 | |
| SCHEMBL2217463 | 0.72 | CD69 (1.00) | CD69ELANESMN1; SMN2CYP2C19PTGDR2 | |
| SCHEMBL7794823 | 0.71 | RXRA (0.41) | CD69ELANECYP2C19RXRAPPARG | |
| SCHEMBL6886563 | 0.71 | RXRA (0.41) | CD69ELANECYP2C19RXRAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9428432-B2 | Derivatives of tris(2-hydroxyphenyl)methanes, preparation thereof and use thereof for mineral oil production | BASF Wintershall Holding GmbH (DE) | 2016-08-30 | — | — | US | disclosed |
| EP-2782666-B1 | DERIVATIVES OF TRIS(2-HYDROXYPHENYL)METHANES, THE PRODUCTION THEREOF AND USE THEREOF FOR OIL PRODUCTION | Wintershall Holding GmbH (DE) | 2016-02-03 | — | — | EP | disclosed |
| US-9212545-B2 | Use of tris(2-hydroxyphenyl)methane derivatives for tertiary mineral oil production | Wintershall Holding GmbH (DE) | 2015-12-15 | — | — | US | disclosed |
| EP-2571923-B1 | DERIVATIVES OF TRIS(2-HYDROXYPHENYL)METHANE, AND PREPARATION AND USE THEREOF | BASF SE (DE) | 2014-12-17 | — | — | EP | disclosed |
| EP-2782666-A1 | DERIVATIVES OF TRIS(2-HYDROXYPHENYL)METHANES, THE PRODUCTION THEREOF AND USE THEREOF FOR OIL PRODUCTION | Wintershall Holding GmbH (DE) | 2014-10-01 | — | — | EP | disclosed |
| EP-2768924-A1 | USE OF TRIS(2-HYDROXYPHENYL)METHANE DERIVATIVES FOR TERTIARY PETROLEUM PRODUCTION | Wintershall Holding GmbH (DE) | 2014-08-27 | — | — | EP | disclosed |
| US-8618321-B2 | Derivatives of tris(2-hydroxyphenyl)methane, their preparation and use | BASF SE (DE) | 2013-12-31 | — | — | US | disclosed |
| US-20130228332-A1 | DERIVATIVES OF TRIS(2-HYDROXYPHENYL)METHANES, PREPARATION THEREOF AND USE THEREOF FOR MINERAL OIL PRODUCTION | BASF Wintershall Holding GmbH | 2013-09-05 | — | — | US | disclosed |
| WO-2013076006-A1 | DERIVATIVES OF TRIS(2-HYDROXYPHENYL)METHANES, THE PRODUCTION THEREOF AND USE THEREOF FOR OIL PRODUCTION | Wintershall Holding GmbH (DE) | 2013-05-30 | — | — | WO | disclosed |
| US-20130098609-A1 | USE OF TRIS(2-HYDROXYPHENYL)METHANE DERIVATIVES FOR TERTIARY MINERAL OIL PRODUCTION | Wintershall Holding GmbH (DE) | 2013-04-25 | — | — | US | disclosed |
| WO-2013057044-A1 | USE OF TRIS(2-HYDROXYPHENYL)METHANE DERIVATIVES FOR TERTIARY PETROLEUM PRODUCTION | Wintershall Holding GmbH (DE) | 2013-04-25 | — | — | WO | disclosed |
| EP-2571923-A1 | DERIVATIVES OF TRIS(2-HYDROXYPHENYL)METHANE, AND PREPARATION AND USE THEREOF | BASF SE (DE) | 2013-03-27 | — | — | EP | disclosed |
| WO-2011144643-A1 | DERIVATIVES OF TRIS(2-HYDROXYPHENYL)METHANE, AND PREPARATION AND USE THEREOF | BASF SE (DE) | 2011-11-24 | — | — | WO | disclosed |
| US-20110288322-A1 | DERIVATIVES OF TRIS(2-HYDROXYPHENYL)METHANE, THEIR PREPARATION AND USE | BASF SE (DE) | 2011-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110288322-A1 | DERIVATIVES OF TRIS(2-HYDROXYPHENYL)METHANE, THEIR PREPARATION AND USE | MGMT, HPGDS, TOP2A | CD69 3183/4885ELANE 547/4885SMN1; SMN2 3964/4885 |
| US-20130228332-A1 | DERIVATIVES OF TRIS(2-HYDROXYPHENYL)METHANES, PREPARATION THEREOF AND USE THEREOF FOR MINERAL OIL PRODUCTION | HPGDS, SQLE, HSD17B4 | CD69 2338/4885ELANE 1807/4885SMN1; SMN2 4817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.